Flow Medical

Flow Medical is a private, pre-revenue medical device startup founded in 2019, targeting the significant clinical and economic burden of pulmonary embolism. The company's core innovation is a smart catheter system that integrates angiography, infusion, and real-time monitoring to enable precision-guided clot dissolution. By providing objective feedback on treatment efficacy, Flow Medical aims to establish a new standard of care for interventional PE treatment, potentially reducing bleeding risks, readmission rates, and long-term complications like pulmonary hypertension.

An integrated, steerable catheter system for catheter-directed thrombolysis (CDT) that combines angiography, infusion, and a real-time feedback mechanism to monitor clot resolution during pulmonary embolism treatment.

The competitive landscape is crowded and includes major medical device companies (e.g., Boston Scientific, Penumbra, Philips) with thrombectomy devices and infusion catheters, as well as other startups. Flow Medical's primary differentiation is its integrated real-time feedback mechanism, aiming to add a layer of precision and data that current 'blind' infusion catheters lack.